Market Access News | pharmaphorum

News

Amazon Pharmacy rolls out insulin discount coupons

Amazon Pharmacy has said that it will automatically apply manufacturer coupons on over 15 insulin and diabetes care products from manufacturers like Novo Nordisk, Eli Lill

News

'Virtual wards' for respiratory infections backed by NICE

NICE has said that patients with acute respiratory infections can be cared for at home rather than in a hospital, with the help of digital platforms that transmit informat

News

After earlier rejection, high-dose Eylea clears FDA

Regeneron and Bayer's efforts to defend their lucrative eye disease therapy Eylea from competition have been boosted by FDA approval of a new high-dose formulation of the

News

Regeneron gets FDA blessing for CHAPLE drug Veopoz

Patients with the ultra-rare disease CHAPLE now have their first FDA-approved therapy, after the regulator approved Regeneron's pozelimab for people aged one and over with

News

Federal appeals court backs limits on abortion pill

A federal appeals court in the US has partially backed a lower court ruling that would restrict access to the medical abortion pill mifepristone, with the dispute now like

News

Keytruda backed for 'basket' of new cancers via NHS

The UK's cost-effectiveness agency NICE has recommended MSD's PD-1 inhibitor Keytruda for a series of cancers based on genetic abnormalities known as microsatellite instab

Amazon Pharmacy rolls out insulin discount coupons

'Virtual wards' for respiratory infections backed by NICE

After earlier rejection, high-dose Eylea clears FDA

Regeneron gets FDA blessing for CHAPLE drug Veopoz

Federal appeals court backs limits on abortion pill

Keytruda backed for 'basket' of new cancers via NHS

GSK to quit Stevenage for new R&D site in Cambridge

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks